Charles A. Kunos, Ph.D.
Affiliations: | 2003 | Case Western Reserve University School of Medicine, Cleveland, OH, United States |
Area:
Physical Anthropology, Anatomy Biology, PaleontologyGoogle:
"Charles Kunos"Parents
Sign in to add mentor| Bruce Latimer | grad student | 2003 | Case Western Medical School | |
| (Cortical and cancellous bone in humans and African apes: Implications for the evolution of bipedality.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kunos CA, Rubinstein LV, Capala J, et al. (2020) Phase 0 Radiopharmaceutical-Agent Clinical Development. Frontiers in Oncology. 10: 1310 |
| Small W, Bosch WR, Harkenrider MM, et al. (2020) NRG Oncology /RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update. International Journal of Radiation Oncology, Biology, Physics |
| Kunos CA, Abdallah R. (2020) Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer. Pharmaceuticals (Basel, Switzerland). 13 |
| Myint ZW, Kunos CA. (2020) Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006-2013. Frontiers in Oncology. 10: 1125 |
| Chauhan A, Kabir T, Wu J, et al. (2020) Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials. Oncotarget. 11: 1427-1434 |
| Kunos C, Ferris G, Waggoner S. (2020) Implementing chemoradiation treatment for patients with cervical cancer in a comprehensive cancer center community oncology practice. Community Oncology. 7: 446-450 |
| Biswas T, Dowlati A, Kunos C, et al. (2020) Base excision repair (BER) inhibitor TRC 102 (Methoxyamine) combined with pemetrexed (PEM)-based chemo-radiation (CRT) for locally advanced non-squamous non-small cell lung cancer (NS-NSCLC): Results of a phase I trial. Journal of Clinical Oncology. 38: 9027-9027 |
| Rychahou P, Chauhan A, Chow Z, et al. (2020) Abstract 6402: DNA-PK inhibitor, M3814, as a radiation sensitizer in the treatment of neuroendocrine tumors Cancer Research. 80: 6402-6402 |
| Kunos CA, Andrews SJ, Moore KN, et al. (2019) Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers. Frontiers in Oncology. 9: 1067 |
| Kunos CA, Capala J, Dicker AP, et al. (2019) Clinical Outcome Assessments Toolbox for Radiopharmaceuticals. Frontiers in Oncology. 9: 1028 |